A precise, reproducible, and sensitive serum neutralization test was developed to estimate Venezuelan equine encephalomyelitis neutralizing antibody activity within 24 hr. The test depends on the interactions of virus with antiviral globulins and of the resultant complexes with anti-gamma globulin (IgG) antibodies. The 50 ~ serum neutralizing dilutions were calculated from the reduction of fluorescent cells in McCoy cell monolayers resulting from the neutralization of infective virus by antibody. In comparative estimates of the neutralizing activity of human and monkey antisera, the sensitivity of the serum neutralization anti-IgG test was several hundredfold greater than that of the conventional serum neutralization test in mice.
INTRODUCTION
Recently, a quantitative assay of Venezuelan equine encephalomyelitis (VEE) virus was developed that depends on the enumeration of cells containing fluorescent viral antigen (Hahon & Cooke, I967) . This assay system was very suitable for characterization of the in vitro interaction between virus and neutralizing antibody (Hahon, I969a ) . The neutralization reaction proceeded initially at a constant rate and then decreased to give a constant level of residual infectivity even in the presence of excess antiviral serum. This was due to the formation of infective virus-antibody complexes (sensitized virus) which could be further neutralized by anti-IgG antibodies not directed against the virus (Hahon, I969b ). An attempt was made, therefore, to increase the sensitivity of the conventional serum neutralization test by the use of anti-IgG serum.
This report describes the development and standardization of a neutralization anti-IgG test for VEE antisera that depends on both the interaction of virus with antiviral globulins and of the resultant complexes with anti-IgG antibodies.
METHODS
Virus and antiviral serum. The source and preparation of the TRINIDAD strain of VEE virus was described previously (Hahon & Cooke, I967) .
VEE antisera were obtained from rhesus monkeys exposed I month earlier to an aerosol of about IOOO cell infecting units (CIU) of virus. Human antiviral sera were obtained from immunized personnel and from a convalescent patient. Sera were inactivated at 56o for 30 rain.
Anti-gamma globulin (IgG) serum. Goat anti-monkey IgG serum was obtained from Microbiological Associates, Bethesda, Maryland. Normal goat serum was purchased from Pentex Laboratories, Kankakee, Illinois.
Cell line. Cells of the McCoy line were used for assay of residual infectivity. Nutrient medium for the cells consisted of Parker's medium 199 containing 0"5 ~ (w/v) lactalbumin hydrolysate, I o ~ foetal calf serum, and 50 #g. of streptomycin and 75 #g. of kanamycin/ml. Cells were maintained in medium ~99 plus 5 ~ foetal calf serum. They were cultivated on circular coverslips 05 mm. diameter) inserted in flat-bottomed glass vials 09 by 65 ram.). One ml. of cell suspension containing Io 5 to 3 x to 5 cells was introduced on to coverslips which were then incubated at 35 ° for 24 hr, or until a complete cell monolayer was formed. Cell monolayers were washed in phosphate-buffered saline (PBS), pH 7" I, free of calcium and magnesium ions, before the addition of inoculum.
Serum neutralization anti-IgG test. Appropriate dilutions of antiviral or normal serum were mixed with equal volumes of a constant quantity of virus (7"4 x Io 4 CIU/ml.). Virus and serum dilutions were routinely prepared in PBS. Test mixtures were incubated at 35 ° for 2 hr. To each test mixture, a ~/2 dilution of goat anti-monkey IgG serum was added in a volume to give a final dilution of r/6. After incubation at 35 ° for to rain., 0.2 ml. of each mixture was introduced on to one of three coverslip cultures of McCoy cells for assay of residual infectivity.
The immunofluorescent cell counting technique (Hahon & Cooke, I967) was employed for assay of virus. Briefly, the virus inoculum was deposited on cell monolayers by centrifugation at I9 to 3ox Io3g for 15 min. Residual fluid was then removed and i ml. of maintenance medium was added. After incubation of coverslip monolayers at 35 ° for I hr to ensure virus penetration into host cells, the cell monolayers were held at 35 ° for 20 hr in the presence of ~ ml. of overlay consisting of I/2o antiviral serum in medium r99. This overlay blocked a second cycle of infection. If cell monolayers were fixed at 12 hr, the antiviral serum overlay was omitted. Infected cell cultures were fixed with cold (-60 °) acetone and either stored at -60 ° or prepared immediately for immunofluorescent staining and counting of infected cells.
Immunofluorescence procedures. Rhesus monkey VEE antiserum was conjugated with fluorescein isothiocyanate (Riggs et al. 1958) ; unbound dye was removed from conjugated globulin by passing through a column of Sephadex G-25. To reduce non-specific fluorescence, 5 m. of conjugated globulin was diluted with an equal volume of PBS and adsorbed twice with 200 mg. of acetone-dried mouse liver powder (Coons & Kaplan, I95o) . The direct method was used to demonstrate immunofiuorescence of viral antigens in infected cells. Fixed cell cultures were washed twice with PBS and stained with conjugated antiserum for 30 min. at room temperature. Coverslip cell monolayers were then washed twice with PBS and stained with conjugated antiserum for 30 min. at room temperature. Coverslip cell monolayers were then rinsed in two changes of PBS and mounted in a semi-permanent medium (Rodriguez & Deinhardt, I96o ).
An American Optical microscope equipped with a Fluorolume illuminator (model 645), exciter filters (Corning no. 584 ° and Schott BG-I2) and barrier filter (E.K. no. 2A) was used to examine stained monolayers. With this system at x 430 magnification, Io64 microscopic fields were contained in the area of a ~5 ram. coverslip. For each coverslip cell monolayer, 50 microscopic fields were examined for fluorescent cells. To calculate the number of CIU of virus/ml., the average number of fluorescent cells/coverslip was multiplied by the number of fields/coverslip, the reciprocal of the dilution of virus inoculum, and by a volume factor for conversion to ml.
Serum neutralization test in mice. In comparisons between this method and the serum neutralization anti-IgG test, a similar protocol and conditions of reactants and reaction were used. Normal goat serum, however, instead of goat anti-monkey IgG serum was added to each virus-antiviral serum mixture. For each test mixture, eight Swiss mice of Io to I4 g. were each inoculated intraperitoneally with o.2 ml. Survivors were recorded daily for I o days. The 5o % serum neutralizing dilutions were calculated by the method of Reed & Muench (I938) .
RESULTS

Parameters of neutralization
Parallel tests were performed to determine the 50 % neutralizing dilution of VEE monkey antiviral serum in the presence of either normal goat serum or goat antiserum to monkey IgG. The percentage reductions of fluorescent cell counts for each antiserum dilution were then plotted on probability paper against the logarithm of the corresponding final dilutions of antiserum. A linear relationship was fitted which gave by interpolation the dilution of antiserum that neutralized 5o % of virus. The 5o % serum neutralizing dilutions in the presence of anti-IgG or normal goat sera were I/zo5,ooo and I/4o,ooo, respectively (Fig. i) . The serum neutralizing activity was more than twofold higher when anti-IgG serum was incorporated into the virus-antiviral serum mixtures. Experiments using the serum neutralization anti-IgG test were made on the influence of various conditions of incubation and reagent concentration on the indication of serum neutralizing activity. The 5o % serum neutralizing activities obtained were comparable N. HAHON whether virus-antiviral serum mixtures were incubated at 35 ° for 2 hr or for longer periods. The additional factor of incubation with anti-lgG serum for IO or 6o rain. at 25 or 35 ° did not effect serum neutralizing activity. For the same incubation time of ½ hr, serum neutralizing activities were approximately twofold higher at 5o ° than at 35 °. At 5 o° for ½ hr, neutralizing activities were comparable to those obtained at 35 ° for 2 hr. In subsequent tests, virus-antiviral serum mixtures were incubated at 35 ° for 2 hr and then with anti-IgG serum at 35 ° for Io rain.
Because previous studies showed that the union of sensitized virus (infective virusantibody complexes) with anti-IgG antibodies occurred within 30 sec. (Hahon, I969b ) , tests were made with an initial mixture of virus, antiserum, and anti-IgG serum incubated at 35 ° for 2 hr in order to determine whether virus neutralization would occur. It might thus be possible to eliminate the second incubation period used for anti-IgG interaction with sensitized virus. Control mixtures with normal goat serum were also tested. Neutralization tests were also made in which virus-antiviral serum mixtures were preincubated at 35 ° for z hr. before either anti-IgG or normal goat serum was added and the mixtures incubated at 35 ° for IO min. The 5 ° ~ serum neutralizing dilutions were determined for each condition. When virus, antiviral serum, and anti-IgG serum were initially mixed and incubated, the serum neutralizing activity (7oo) was about 5o-fold lower than that in mixtures containing normal goat serum (4o,ooo). The serum neutralizing activity was unchanged when normal goat serum was added to mixtures initially or after the primary incubation period. When anti-IgG serum was added to virus-antiviral serum mixtures after the primary incubation period, the serum neutralizing activity was 15o-fold higher (IO5,OOO) than that obtained by mixing these reactants together before incubation. These data emphasize the importance of incubating virus-antiviral mixtures for a suitable time before adding anti-IgG serum.
To determine the effect of virus concentration on the serum neutralizing activities, neutralization tests were made which differed only in the quantity of virus that reacted with appropriate dilutions of antiviral and anti-IgG sera. Tenfold differences in virus concentration did not significantly change the 5o ~ serum neutralizing activity (Table I) . This is consistent with the 'percentage law' of Andrewes & Elford (t933).
To determine the influence of different dilutions of anti-IgG serum on the serum neutralizing activity, a constant quantity of virus was mixed with appropriate dilutions of antiviral serum and incubated at 35 ° for 2 hr. Samples of each virus-antiserum mixture were then taken and to each was added a different dilution of anti-lgG serum. The neutralizing activity was unchanged when I/6 or i/30 anti-IgG serum was reacted with virus-antiviral serum mixtures (Table z) . Sufficient anti-IgG antibodies were apparently present at these dilutions to saturate sensitized virus. With dilutions of anti-lgG serum beyond 1/3o, the Neutralization anti-IgG test for VEE antibody z8 9 indicated neutralizing activity decreased. To ensure that anti-IgG antibodies were available in excess in serum neutralization tests, a final dilution of I/6 of anti-IgG serum was routinely employed. Normal goat serum 44,000 * Reciprocal of 50 ~ serum neutralizing dilution. 
Quantitative evaluation of antibody activity
The precision of the serum neutralization anti-IgG test was estimated in ten determinations made under identical conditions. The standard deviation of antibody activity was 4"7 of the mean activity (lo7,9oo). In the immunofluorescent serum neutralization test for psittacosis (Hahon & Cooke, I965) , the standard deviation of antibody activity was 3"4 ~.
To determine the reproducibility of estimates of neutralizing activity, four identical tests were made at intervals over a period of 3 weeks. The reproducibility attained ( Table 3 ) was such that twofold or greater differences in serum neutralizing activity were significant.
The sensitivity of the serum neutralization anti-lgG test was compared with that of the conventional serum neutralization test in mice for estimation of VEE antibodies in human rhesus monkey sera. Goat anti-monkey IgG serum was employed in the former test because it is equally effective in neutralizing virus sensitized by either human or monkey antiviral serum (Hahon, I969b) . Significantly higher antibody activities were indicated for all sera when the serum neutralization anti-IgG test was used (Table 4 ). The average differences in antibody activity obtained between the two sets were about 4oo-and 3oo-fold for human and monkey antisera, respectively.
DISCUSSION
The serum neutralization anti-IgG test described in this report for the estimation of VEE neutralizing antibody activity depends on both the interaction of virus with antiviral antibodies and of the resultant complexes with anti-IgG antibodies. The optimal conditions required for neutralization of virus infectivity in these reactions has been defined. Previously, it was shown (Hahon, I969a ) that residual infectivity was due to the presence of infective virus-antibody complexes (sensitized virus) that could be neutralized by anti-IgG antibody inactive against the virus particle (Hahon, 1969 b) . It is the latter reaction with anti-IgG antibody that significantly enhances the sensitivity of antibody detection (Notkins et al. I968 ). It has been postulated that anti-IgG antibodies form bridges that cover critical infective sites on the virus particle or stabilize the attachment of antiviral antibody to virus (Notkins et al. I966; Ashe & Notkins, ~966) . The mechanism by which infective virus-antibody complexes may be neutralized by anti-IgG serum has not been resolved completely.
The high precision and reproducibility of estimates of 5o ~ serum neutralizing activity by the serum neutralization anti-IgG test are a consequence of the assay procedure employed to measure residual infectivity (Hahon & Cooke, I967) . Twofold differences in antibody activity were significant. In comparative estimates of VEE neutralizing antibodies in human and monkey sera, the sensitivity of the serum neutralization anti-IgG test was from 3oo-to 4oo-fold greater than that of the direct serum neutralization test in mice. In addition, the ability of the former test to determine antibody activity within 24 hr is an important advantage for diagnostic purposes. The principle of the serum neutralization anti-IgG test in conjunction with the immunofluorescent cell-counting assay of residual infectivity may be applicable to the studies on other virus systems.
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